Sinclair non-exec takes more shares
A round-up of the biggest director buys today so far.
Jean-Charles Tschudin, a non-executive director at the skin care products supplier Sinclair Pharma, has added to his holding in the company with the purchase of 56,000 shares at 36p a time.
He now has 967,117 shares, which is about 0.4% of the company.
Top Director Buys
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Qatar Investment Fund (QIF) Director name: Mr David von SimsonAmount purchased: 75,000 @ $0.93 Value: $69,750
Sinclair Pharma (SPH) Director name: Mr Jean-Charles TschudinAmount purchased: 56,000 @ 36.00p Value: £20,160
Witan Inv Trust (WTAN) Director name: Mr Robert W BoyleAmount purchased: 2,024 @ 525.00p Value: £10,626
Top Director Sells
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
MoneyWeek is written by a team of experienced and award-winning journalists, plus expert columnists. As well as daily digital news and features, MoneyWeek also publishes a weekly magazine, covering investing and personal finance. From share tips, pensions, gold to practical investment tips - we provide a round-up to help you make money and keep it.
-
Will “Liberation Day” strike again?
Donald Trump’s 90-day tariff pause comes to an end on 9 July. Can we expect further market turmoil?
-
Israel claims victory in the '12-day war' with Iran
Donald Trump may have announced a ceasefire in the 12-day war between Israel and Iran, but what comes next depends on what happens internally in Iran